Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -5.18 | -5.88 | -2.56 | -3.66 |
Depreciation/ Depletion | 0.72 | 0.62 | 0.62 | 0.73 |
Non- Cash Items | 1.22 | 1.21 | 0.83 | 1.52 |
Changesin Working Capital | -1.68 | 2.34 | 0.12 | -5.34 |
Cashfrom Operating Activities | -4.91 | -1.71 | -0.99 | -6.75 |
Capital Expenditures | -0.79 | -1.27 | -0.01 | -0.30 |
Cashfrom Investing Activities | -0.79 | -1.27 | -0.01 | -0.30 |
Financing Cash Flow Items | -1.22 | -1.56 | 0.26 | -1.55 |
Issuance( Retirement)of Stock Net | 8.26 | 6.92 | 0.00 | 9.00 |
Issuance( Retirement)of Debt Net | -1.45 | -2.25 | 0.67 | -0.49 |
Cashfrom Financing Activities | 5.59 | 3.11 | 0.94 | 6.96 |
Net Changein Cash | -0.11 | 0.13 | -0.07 | -0.09 |
Cash Interest Paid | 1.22 | 1.21 | 0.90 | 1.55 |
Cash Taxes Paid | 0.00 | -1.05 | 0.00 | 0.00 |
Vista Pharmaceuticals Dividend Vista Pharmaceuticals Bonus Vista Pharmaceuticals News Vista Pharmaceuticals AGM Vista Pharmaceuticals Rights Vista Pharmaceuticals Splits Vista Pharmaceuticals Board Meetings Vista Pharmaceuticals Key Metrics Vista Pharmaceuticals Shareholdings Vista Pharmaceuticals Profit Loss Vista Pharmaceuticals Balance Sheet Vista Pharmaceuticals Q1 Results Vista Pharmaceuticals Q2 Results Vista Pharmaceuticals Q3 Results Vista Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks